Afran, Louise, Jambo, Kondwani ORCID: https://orcid.org/0000-0002-3195-2210, Nedi, Wilfred, Miles, David J C, Kiran, Anmol, Banda, Dominic H, Kamg’ona, Ralph, Tembo, Dumizulu, Pachnio, Annette, Nastouli, Eleni, Ferne, Brigit, Mwandumba, Henry ORCID: https://orcid.org/0000-0003-4470-3608, Moss, Paul, Goldblatt, David, Rowland-Jones, Sarah, Finn, Adam and Heyderman, Robert S (2022) 'Defective monocyte enzymatic function and an inhibitory immune phenotype in HIV-exposed uninfected African infants in the era of antiretroviral therapy'. Journal of Infectious Disease, Vol 226, Issue 7, pp. 1243-1255.
|
Text
jiac133.pdf - Published Version Available under License Creative Commons Attribution. Download (1MB) | Preview |
Abstract
Background
HIV-Exposed Uninfected (HEU) infants are a rapidly expanding population in sub-Saharan Africa, highly susceptible to encapsulated bacterial disease in the first year of life. The mechanism of this increased risk is still poorly understood. We investigated if HIV-exposure dysregulates HEU immunity, vaccine-antibody production and human herpes virus (HHV) amplify this effect.
Methods
34 HIV-infected and 44 HIV-uninfected pregnant women were recruited into the birth cohort, followed up to 6 weeks of age; and 43 HIV-infected and 61 HIV-uninfected mother-infant pairs into a longitudinal infant cohort, at either: 5-7 to 14-15; or 14-15 to 18-23 weeks of age. We compared monocyte function, innate and adaptive immune cell phenotype, and vaccine-induced antibody responses between HEU and HU infants.
Results
We demonstrate altered monocyte phagosomal function and B cell subset homeostasis, and lower vaccine-induced anti-Haemophilus influenzae type b (Hib) and anti-Tetanus Toxoid (TT) IgG titers in HEU compared to HU infants. HHV infection was similar between HEU and HU infants.
Conclusion
In the era of antiretroviral therapy (ART)-mediated viral suppression, HIV-exposure may dysregulate monocyte and B cell function, during the vulnerable period of immune maturation. This may contribute to the high rates of invasive bacterial disease and pneumonia in HEU infants.
Item Type: | Article |
---|---|
Subjects: | QU Biochemistry > Enzymes > QU 135 Enzymes QW Microbiology and Immunology > Immunity by Type > QW 541 Natural immunity. Immunogenetics QW Microbiology and Immunology > Antigens and Antibodies. Toxins and Antitoxins > QW 575 Antibodies QW Microbiology and Immunology > Immunotherapy and Hypersensitivity > QW 805 Vaccines. Antitoxins. Toxoids WC Communicable Diseases > Virus Diseases > Acquired Immunodeficiency Syndrome. HIV Infections > WC 503 Acquired immunodeficiency syndrome. HIV infections WS Pediatrics > By Age Groups > WS 430 Infancy |
Faculty: Department: | Clinical Sciences & International Health > Malawi-Liverpool-Wellcome Programme (MLW) |
Digital Object Identifer (DOI): | https://doi.org/10.1093/infdis/jiac133 |
SWORD Depositor: | JISC Pubrouter |
Depositing User: | JISC Pubrouter |
Date Deposited: | 16 Aug 2022 13:25 |
Last Modified: | 14 Jun 2023 11:34 |
URI: | https://archive.lstmed.ac.uk/id/eprint/20293 |
Statistics
Actions (login required)
Edit Item |